Nadja Thomas

Polyclonal Evolution of Multiple Secondary <i>KIT</i> Mutations in Gastrointestinal Stromal Tumors under Treatment with Imatinib Mesylate

Eva Wardelmann, Sabine Merkelbach‐Bruse, Katharina Pauls et al. · Clinical Cancer Research · 2006 · 360 citations

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

Eva Wardelmann, Nadja Thomas, Sabine Merkelbach‐Bruse et al. · The Lancet Oncology · 2005 · 191 citations

Chromatin, Multiple Kit Mutations, Oncology +10

Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models

Karsten Geletneky, Irina Kiprianova, A. Ayache et al. · Neuro-Oncology · 2010 · 98 citations · Full text

Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1

Irina Kiprianova, Nadja Thomas, A. Ayache et al. · Clinical Cancer Research · 2011 · 32 citations